Joincare Pharmaceutical Group Industry Co., Ltd
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Joincare Pharmaceutical Group Industry Co., Ltd
RECRUITINGPhase 3NCT07357051
Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric...
The goal of this phase III study is to learn if JKN2301 Dry Suspension works to treat uncomplicated influenza in Pediatric Participants aged 2 to 11 years.
Sponsor: Joincare Pharmaceutical Group Industry Co., LtdEnrolling: 1771 location
Respiratory Viral Infection
RECRUITINGPhase 1NCT07207291
Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers
This Phase I study is a randomized, double-blind, placebo-controlled, dose-escalation trial conducted at a single center. It consists of two parts: Part 1 (SAD): Evaluates the...
Sponsor: Joincare Pharmaceutical Group Industry Co., LtdEnrolling: 661 location
Bacterial InfectionsUrinary Tract InfectionsIntra-Abdominal Infections+1